Loading...
Efficacy and safety of an intravenous C1-inhibitor concentrate for long-term prophylaxis in hereditary angioedema
BACKGROUND: The plasma-derived, pasteurized, nanofiltered C1-inhibitor concentrate (pnfC1-INH) is approved in the United States as an intravenous (IV) on-demand treatment for hereditary angioedema (HAE) attacks, and, in Europe, as on demand and short-term prophylaxis. OBJECTIVE: This analysis evalua...
Na minha lista:
| Udgivet i: | Allergy Rhinol (Providence) |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
OceanSide Publications, Inc.
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5380447/ https://ncbi.nlm.nih.gov/pubmed/28381322 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2500/ar.2017.8.0192 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|